<bill session="116" type="s" number="3781" updated="2020-06-30T04:28:31Z">
  <state datetime="2020-05-20">REFERRED</state>
  <status>
    <introduced datetime="2020-05-20"/>
  </status>
  <introduced datetime="2020-05-20"/>
  <titles>
    <title type="short" as="introduced">PART Act</title>
    <title type="short" as="introduced">PART Act</title>
    <title type="short" as="introduced">Pharmaceutical Accountability, Responsibility, and Transparency Act</title>
    <title type="short" as="introduced">Pharmaceutical Accountability, Responsibility, and Transparency Act</title>
    <title type="display">PART Act</title>
    <title type="official" as="introduced">A bill to increase reporting of, help mitigate potential shortages related to, and promote, accountability and transparency for pharmaceuticals and medical devices.</title>
  </titles>
  <sponsor bioguide_id="P000595"/>
  <cosponsors/>
  <actions>
    <action datetime="2020-05-20">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-05-20" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Government information and archives"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Strategic materials and reserves"/>
    <term name="Trade restrictions"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
